The American Food and Drug Administration recently approved a drug developed in Israel to treat Parkinson’s disease. Azilect, which is now available to patients, is the first Parkinson’s medication with once-daily dosage. Professors at the Technion-Israel Institute of Technology in Haifa worked alongside Israeli pharmaceutical company Teva to develop the drug.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
